Paige
Creates AI-native digital pathology software to assist pathologists in diagnosing cancer.
What they do
Paige provides artificial intelligence applications and digital pathology tools to healthcare institutions. The software assists pathologists in detecting, characterizing, and grading breast and prostate cancers from tissue biopsies, aiming to improve diagnostic accuracy and efficiency in pathology laboratories.
The record
- Vertical
- Oncology
- Sub-segment
- AI digital pathology
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- New York, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $220M raised
Notable investors: Casdin Capital, Johnson & Johnson Innovation, KKR, Breyer Capital.